Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO

107
9
Favorite

Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO

Bloomberg2021-07-22

(Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is considering fundraising options including an initial public offering, according to people familiar with the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

107

Report

Comment（9）

sickeninglim
·2021-07-22
Wow....
Reply
Like
Report
xinyann
·2021-07-22
nice
Reply
3
Report
Jun32
·2021-07-22
Comment
Reply
2
Report
DansonYong
·2021-07-22
Niceee
Reply
2
Report
Cellycel
·2021-07-22
Nice
Reply
3
Report
百万王子
·2021-07-22
Good
Reply
4
Report
WannaBluffy
·2021-07-22
That's good news.
Reply
6
Report
Fold Replies
- hui1234567:
  great!
  2021-07-22
  Reply
  Report
- Leoneon8881:
  ??
  2021-07-22
  Reply
  Report
FU5591
·2021-07-22
ok
Reply
3
Report
Fold Replies
- Xann:
  Ok
  2021-07-22
  Reply
  Report
土金水木火
·2021-07-22
Ok
Reply
7
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2153643390?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-22 10:03","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2153643390","market":"us","top_or_hot":-1,"title":"Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO","media":"Bloomberg","content":"<div>\n<p>(Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is considering fundraising options including an initial public offering, according to people familiar with the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/amgen-backed-biotech-firm-hummingbird-101322071.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-22 10:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/amgen-backed-biotech-firm-hummingbird-101322071.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is considering fundraising options including an initial public offering, according to people familiar with the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/amgen-backed-biotech-firm-hummingbird-101322071.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMGN","symbol_name":"安进","start_time":0,"source_url":"https://finance.yahoo.com/news/amgen-backed-biotech-firm-hummingbird-101322071.html","article_id":"2153643390","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2153643390","pubTimestamp":1626919402,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"(Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is consideri","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AMGN":"安进"},"translate_title":"安进（Amgen）支持的生物技术公司蜂鸟（Hummingbird）正在考虑美国IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMGN":0.9},"content_text":"(Bloomberg) -- Hummingbird Bioscience, a Singaporean clinical-stage biotechnology firm, is considering fundraising options including an initial public offering, according to people familiar with the matter.\nThe company is interviewing investment banks as it weighs alternatives, which also include a private funding round, the people said, asking not to be identified because the matter is private.\nHummingbird could seek to raise about $200 million to $300 million in a share sale, which could take place as soon as later this year, the people said. The company is leaning toward the U.S. as a preferred listing venue, they added.\nIt plans to use part of the proceeds to support business expansion, the people said. No final decision has been made, the people said. Details such as the type of fundraising, size and timing could still change, they said.\nHummingbird Bioscience is unable to comment on the speculation regarding an IPO, it said in an emailed statement in response to a Bloomberg News query. As a growth-stage biotech company, Hummingbird is continuously exploring future financing options, and remains focused on delivering against its development program and strategy, it said.\nThe company focuses on developing treatments in areas such as oncology and autoimmunity in collaboration with global partners in academia and industry, according to its website.\nHummingbird raised $125 million in a series C financing round in May led by Novo Holdings, the Danish private investor which is the controlling shareholder in Novo Nordisk A/S, the world’s largest maker of insulin. Other investors include Amgen Ventures, the venture capital arm of U.S. biotech giant Amgen Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":172920870,"gmtCreate":1626928470890,"gmtModify":1703480779482,"author":{"id":"3575453671192179","authorId":"3575453671192179","name":"sickeninglim","avatar":"https://static.tigerbbs.com/0753a2906468fc16c39e5f831b2200d7","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":1,"idStr":"3575453671192179","authorIdStr":"3575453671192179"},"htmlText":"Wow....","listText":"Wow....","text":"Wow....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172920870","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":172021138,"gmtCreate":1626921880624,"gmtModify":1703480642056,"author":{"id":"3583574689072529","authorId":"3583574689072529","name":"xinyann","avatar":"https://static.tigerbbs.com/cbc5113d2391238669e74c2d5c7fb706","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3583574689072529","authorIdStr":"3583574689072529"},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172021138","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":172065900,"gmtCreate":1626921515800,"gmtModify":1703480633925,"author":{"id":"3570675498789498","authorId":"3570675498789498","name":"Jun32","avatar":"https://static.tigerbbs.com/e0384bd36af93ff46ff6cb210e0674f8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3570675498789498","authorIdStr":"3570675498789498"},"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172065900","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":172068497,"gmtCreate":1626921404419,"gmtModify":1703480629831,"author":{"id":"3577608661218389","authorId":"3577608661218389","name":"DansonYong","avatar":"https://static.tigerbbs.com/d847e6b2cafe58e68ceb1d9adcb8038f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3577608661218389","authorIdStr":"3577608661218389"},"htmlText":"Niceee","listText":"Niceee","text":"Niceee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172068497","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":172068591,"gmtCreate":1626921396413,"gmtModify":1703480630979,"author":{"id":"3582080395234163","authorId":"3582080395234163","name":"Cellycel","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582080395234163","authorIdStr":"3582080395234163"},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172068591","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":172088809,"gmtCreate":1626920862101,"gmtModify":1703480615355,"author":{"id":"3585533190234168","authorId":"3585533190234168","name":"百万王子","avatar":"https://static.tigerbbs.com/ddf905b898fe0752bea7c6d549654cb4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585533190234168","authorIdStr":"3585533190234168"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172088809","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":172011413,"gmtCreate":1626920280432,"gmtModify":1703480599783,"author":{"id":"3586986998667843","authorId":"3586986998667843","name":"WannaBluffy","avatar":"https://static.tigerbbs.com/1dd14463a45a95644b65d2bd68777ecd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586986998667843","authorIdStr":"3586986998667843"},"htmlText":"That's good news.","listText":"That's good news.","text":"That's good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/172011413","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5289730,"gmtCreate":1626920744025,"gmtModify":1663231301827,"authorId":4087899267516000,"author":{"id":4087899267516000,"idStr":"4087899267516000","authorId":4087899267516000,"name":"hui1234567","avatar":"https://static.tigerbbs.com/f1ef5eb26f8ef01d38bcf417264003a1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":172011413,"type":1,"supId":5289712,"prevId":0,"content":"great!","text":"great!","html":"great!"},{"id":5289712,"gmtCreate":1626920560254,"gmtModify":1663231301231,"authorId":3556969222862067,"author":{"id":3556969222862067,"idStr":"3556969222862067","authorId":3556969222862067,"name":"Leoneon8881","avatar":"https://static.tigerbbs.com/f538101c460b5f022a9dba30ce236442","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":172011413,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"}],"langContent":"EN"},{"id":172038378,"gmtCreate":1626919837094,"gmtModify":1703480587401,"author":{"id":"3572502301692301","authorId":"3572502301692301","name":"FU5591","avatar":"https://static.tigerbbs.com/a0762ea32f762ec6978abe3695419890","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572502301692301","authorIdStr":"3572502301692301"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/172038378","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5289639,"gmtCreate":1626920056669,"gmtModify":1663231300941,"authorId":3582771700317616,"author":{"id":3582771700317616,"idStr":"3582771700317616","authorId":3582771700317616,"name":"Xann","avatar":"https://static.tigerbbs.com/b936c65d357a7d2d686ad9e6335c3c18","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":172038378,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"EN"},{"id":172030384,"gmtCreate":1626919630648,"gmtModify":1703480579788,"author":{"id":"4087537231786360","authorId":"4087537231786360","name":"土金水木火","avatar":"https://static.tigerbbs.com/b569dff568eac68113202875c896b710","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087537231786360","authorIdStr":"4087537231786360"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172030384","repostId":2153643390,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":107,"commentSize":9,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}